17^th European Diabetes and Endocrinology Congress

Dr. George Perry received his PhD in Marine Biology from Scripps Institution of Oceanography, University of California at San Diego. He completed his Postdoctoral Fellowship in the Department of Cell Biology, Baylor College of Medicine, Houston, Texas.Dr. Perry joined the UTSA faculty in 2006 from Case Western Reserve University where he was Professor of Pathology and Neurosciences and Chair of the Department of Pathology. He is also distinguished as one of the top 20 Alzheimers disease researchers with over 800 publications, one of the top 100 most-cited scientists in Neuroscience & Behavior and one of the top 25 scientists in Free Radical research . He currently serves as and President for the American Association of Neuropathologists. He is on the editorial board of over 60 journals including American Journal of Pathology and Journal of Biological Chemistry, and is Editor-in-Chief of Journal of Alzheimer’s Disease.

Mechanism for RNA-based redox metal binding consequences of RNA oxidation on protein synthesis rate and fidelity role of redox active metals in mediating prooxidant and antioxidant properties signal transduction pathways altered in Alzheimer disease that allow neurons to evade apoptosis mechanism of phosphorylation control of oxidative damage to neurofilament proteins

Dr. Arturo Solís Herrera, MD, PhD., has been Graduated from Institute Polytechnic Nacional, from CDMX, in 1978 as Medicine Doctor, with the specialties including Ophthalmology, in the National University of Mexico, and Neuro-Ophthalmology, at INNN, México. Later on he obtained his Master Science Degree from University of Aguascalientes, México, and thereafter a PhD in Pharmacology, Universidad de Guadalajara, México. Dr. Solís Herrera is director and founder of Human Photosynthesis® Research Center, in Ags., México, in 2007; where he has continued his research until today.

The discovery of a biochemical process, that from a molecule that exists on the skin, hair and coating the human retina but can be produced artificially, (melanin or polihidroxiindol), is capable of breaking the molecule water, separating the hydrogen and oxygen and extracting energy from this process. The raw material of this invention is abundant in nature, as its core components are water and a molecule that exists in the skin, hair and the lining of the human retina, but that can be produced artificially: melanin or polihidroxiindol.

Dr. L0pes-Virella is one of most famous doctor in the Charleston, Lopes-Virella is practicing in medical field for 48 Years. Doctor Maria completed its graduation from Other in the year 1967 and was awarded with degree by the medical institute OTHER. From 48 years Dr. Maria F Lopes-Virella had been awarded by local authorities in the state SC, USA.

Immune complex formation in human diabetic retina enhances toxicity of oxidized LDL towards retinal capillary pericytes

Shaaban Abdallah, a professor of Aerospace Engineering, has been at the university of Cincinnati since 1989. He obtained his PhD in Aerospace Engineering at the university of Cincinnati in 1980. Dr. Abdallah joined Penn State University from 1981 to 1988. His research interests include Computational Fluid Dynamics, nano fluids, Turbo-machines, Unmanned Aerial Vehicles and Medical devices. Abdallah has two US patents on centrifugal compressors and three disclosures with university of Cincinnati on medical devices.

Energy loss And coronary flow simulation following hybrid stage l palliation: a hypoplastic left heart computational fluid dynamic model, Interactive cardiovascular and Thoracic Surgery.

Malcolm Carruthers is a Founder and Chief Medical Consultant to the Centre for Men's Health, He has spent 30 years on research into testosterone treatment. He is Adjunct Professor at the Alzheimer's and Aging Department, Edith Cowan University, Western Australia as well as being a Fellow of the Royal College of Pathologist. He is a life member of the Royal College of General Practitioners (RCGP). He is also President of the Society for the Study of Androgen Deficiency (Andropause Society), a member of the British Cardiovascular Society, the European Academy of Andrology, the International and European Societies for the Study of the Aging Male and a past President of the Society for Psychosomatic Research.

Malcolm Carruthers is interested in Testosterone Replacement Therapy (TRT) in 1977 when he saw the remarkable results being obtained by the pioneer of the treatment, Dr Jen Moller, in Copenhagen. In 1988 Dr Carruthers set up what is now the Centre For Men's Health in Harley Street, specialising in the diagnosis and treatment of testosterone deficiency- the male menopause- or andropause. He subsequently became a member of the European Academy of Andrology and International and European Societies for the Study of the Aging Male.

Dr. Vincenzo Costigliola has more than 40 years of medical practice after graduating in Medicine at the University of Naples (Italy), and a post-degree specialization in Anesthesiology and Intensive Care from the Università di Pisa (Italy). He is a Founder & President of European Medical Association (Belgium). He has also co-founded the European Association for Preventive, Predictive and Personalized Medicine, and is current President (Belgium). He was formerly the Chief of Medical Services in the Italian Navy. Over the years, Dr Costigliola has widened his specializations into Rheumatology, Dermatology, Proctology, Oncology, Surgery, Drug Abuse, Emergency Treatment, and Disaster Action.

Medical Teaching Methodology, Computer and Audio-Visual for the Medical Profession.

Palayakotai Raghavan is CEO and Founder of Nanorx INC. He completed Ph.D in Organic Chemistry from Oregon State University (1979) and M.S in Chemistry (1972) from I.I.T Mumbai, India. He has worked on drug discovery for over 25 years at Columbia University, Max-Planck Institute, Germany, Ciba-Geigy (now Novartis) and Boehringer Ingelheim. He has over 12 patents and another 15 pending patent applications.

The present invention provides nanoparticulate policosanol, and octacosanol formulations including these particles, as a well as methods of using the particles and formulations for treatment and prophylaxis of various diseases and conditions.

Rui Santos Cruz is PhD in Health Sciences - Faculty of Medicine. University of Coimbra; MSc in Health Sociopsychology; Bachelor Degree in Pharmacy and Postgraduate in Law of Pharmacy and Medicine. He is coordinator professor in Polytechnic Institute of Coimbra, ESTESC-Coimbra Health School, Department of Pharmacy, Portugal.

Drug Utilization Studies; Therapeutics for Diabetes type 2; Therapeutic Adherence and its Determinants.

Nandakumaran obtained his Doctorate degree in Reproductive Physiology from University of Paris in 1979 and worked as post-doctoral research consultant for 4 years in Hospital St Vincent De Paul, Paris, France & was visiting Faculty at New York medical Centre for a few weeks and worked as Chairman of Obstetrics & Gynecology Department, Kuwait Medical Faculty for over 4 years. He has published over 50 research papers in international journals relating to maternal-fetal exchange of nutrients and drugs in health and disease.

DrNandakumaran research interest in maternal-fetal exchange of nutrients and drugs in humans and animals in normal and disease states and has publsihed nearly 90 research papers in International Scientific Journals as well as in International Conferences

Irina Kurnikova has become Doctor of Medical Sciences (PhD) in 2010, the first academic degree (MD) received at the age of 28 years. Dealing with Problems of Endocrinology more than 20 years. Irina Kurnikova had led a course of endocrinology at the Medical Academy (Izhevsk, Russia), endocrinology department at the Russian Scientific Center of Medical Rehabilitation and Health Resort (Moscow, Russia). Currently she teaches at Peoples' Friendship University of Russia, curator of the scientific direction of endocrinology. Irina Kurnikova has published more than 20 articles in well-known journals, the author of 25 books and manuals in Russian, 9 patents for inventions.

Irina Kurnikova research interest in regulatory system in diabetes type 2

Dr. Belma, has completed the Faculty of Medicine in Sarajevo in 1989. After completing her Postgraduate studies in 1997, She obtained a Master of Science degree and also completed the doctoral studies in the field of Diabetology in 2005. She passed the internal medicine exam in 1996, after four years of the specialization program. In 2010, she completed endocrinology and Diabetology specialization. She was elected as Assistance Professor in Medical university of Sarajevo in 2006, after 5 years she was promoted to Associate Professor.

Dr. Belma research interest in type 1 and type 2 diabetes, a disorder of the thyroid, pituitary, adrenal and parathyroid glands, obesity, metabolic and reproductiv disorders.

Hidekatsu Yanai, MD, PhD, Fellow of American College of Physicians (FACP), is the Director of the Department of Internal Medicine and Clinical Research and Trial Center, National Center for Global Health and Medicine Kohnodai Hospital, Japan. He obtained his MD and PhD degrees in National Defense Medical College and Hokkaido University School of Medicine, respectively. He studied as Invited PhD Research Fellow in the National Institutes of Health (NIH), USA (2002-2004). He is the Editor-in-Chief of Journal of Endocrinology and Metabolism and also an Editorial Board Member of ten medical journals. He has 153 published papers in refereed medical journals.

Hidekatsu Yanai research interest includes atherosclerosis, diabetes, endocrinology, obesity and lipid metabolism.

Nelofar Sami Khan is a Associate Professor in Deptment of Biochemistry at Gulf Medical University, Ajman, UAE. Nelofar Sami Khan has Completed her Phd in the Deptment of Biochemistry, Faculty of life sciences at Aligarh Muslim University.

Nelofar Sami Khan research interest in Knowledge and attitude towards blood donation a cross sectional survey among the population of UAE. Soluble lectin-like oxidized low-density lipoprotein receptor-1 (sLOX-1) level in serum of normal and type 2 Diabetic subjects and and antioxidant status in type 2 diabetic patients and their correlation with early diabetic complications

Bin Xue is a Vice Secretary-General of Jiangsu Society For Cell and Developmental Biology Member of China Society for Cell Biology.

Metabolic disturbance and tumor occurrence. The function of protein phosphorylation and prenylation in regulating the liver injury. New natural drug screen for metabolic diseases.

Hidekatsu Yanai, MD, PhD, Fellow of American College of Physicians (FACP), is the Director of the Department of Internal Medicine and Clinical Research and Trial Center, National Center for Global Health and Medicine Kohnodai Hospital, Japan. He obtained his MD and PhD degrees in National Defense Medical College and Hokkaido University School of Medicine, respectively. He studied as Invited PhD Research Fellow in the National Institutes of Health (NIH), USA. He is the Editor-in-Chief of Journal of Endocrinology and Metabolism and also an Editorial Board Member of ten medical journals. He has 181 published papers in refereed medical journals.

Dr. Hidekatsu Yanai research interest includes atherosclerosis, diabetes, endocrinology, obesity and lipid metabolism

Dr. Ian Martins is a Reveiwer for Open Acess Pub and various other international journals. Appointed as the Chief Editor for International Journal of Diabetes Research (2014-2017), Research and Reviews: Neuroscience (2016-2017)/Journal of Diabetes and Clinical Studies and Editor for various journals. He is a BIT Member (BIT Congress. Inc) with an H-index of 43, (ResearchGate STATs (23), Mendeley STATS (20). He is now a Scientist for The Science Advisory Board (USA) and an Academic with Academia.edu. ResearchGate’s analysis available on google, Tweet, Facebook, Lindekin under Ian James Martins’ name places publication Stats RG score higher than 96% of the international SCIENTISTS. Prestigious Recognition of Lifetime Membership by International Agency for Standards and Ratings as Fellow for Diabetes, Medical Science (Nutrition), Endocrinology and Metabolism.Conferred with the RICHARD KUHN RESEARCH AWARD-2015 ENDOCRINOLOGY AND METABOLISM. Winner (World Academic Championship -2017) in Diabetes and Medical Science (Nutrition).

Diabetes & Endocrinology

Dr. Mohammad Delwer Hossain Hawlader, PhD is a medical scientific professional with having 17 years of professional experience, which included more than 11 years experiences in public health research and project management and 4 years experience of teaching in public health. Currently he has been working as Assistant Professor and Chairman, Department of Public Health at North South University (NSU), Bangladesh.

Diabetes & Endocrinology

Gina Rayat received her Bachelor of Science degree major in Molecular Biology at the University of Winnipeg and completed her Master of Science degree in Transplantation Immunology at the University of Manitoba. She completed her PhD training at the University of Alberta and moved to Denver, Colorado, USA for a postdoctoral training at the Barbara Davis Center for Childhood Diabetes. She returned to Edmonton and was appointed Assistant Professor in the Department of Surgery at the University of Alberta. She is now Professor in the same department and the Director of the Ray Rajotte Surgical-Medical Research Institute, which is a state of the art facility for surgical education, training, and research at the University of Alberta. Her focus of research is to understand the mechanism(s) of islet graft rejection and to develop safer strategies for preventing rejection and induction of tolerance to islet grafts.

Islet xenotransplantation, tansplantation tolerance, autoimmunity (type 1 diabetes)

Yanfei (Jacob) Qi is establishing his scientific reputation in lipid research. He is currently Head of Diabetes Lipid Metabolism Laboratory at Centenary Institute, The University of Sydney (USYD), Australia. His current research focuses on the lipid metabolism and signaling in type 2 diabetes (T2D). Jacob commenced his research career with pharmacological studies of anti-diabetic medicines at USYD, and then continued his research as foreign co-researcher at Kyoto University, Japan. Jacob obtained his PhD at Sydney Medical School, USYD. His PhD study focused on sphingolipid signaling and lipotoxicity in T2D and NAFLD. More recently, he was research fellow at The University of NSW, Australia, where he developed research expertise in phospholipid metabolism, intracellular lipid transport and lipid droplet biology. Jacob published a number of well-cited first-author papers in the past 5 years. His research output has been increasing as reflected in the number of publication and citation per annum.

Dysregulated lipid metabolism is a well-known risk factor in the development of type 2 diabetes. Ectopic lipid accumulation in the liver causes insulin resistance, while lipid overloading of pancreatic islets impairs insulin secretion due to lipotoxic stress. Our research focuses on multiple aspects of lipid metabolism: how sphingolipids and phospholipids regulate hepatic insulin resistance both in vivo and in vitro; how sphingolipids determine pancreatic beta-cell viability; how neutral lipids are stored and mobilised in adipocytes; and how phospholipids are transported within cells. In addition to lipid studies in the pathogenesis of type 2 diabetes, we also aim to identify lipid biomarkers for diabetes at early diagnosis. The majority of pre-diabetic subjects proceed to type 2 diabetes, however, prediabetes is usually unrecognised, which constitutes a major public health concern. Thus, identification of high-risk individuals via a biomarker is urgently needed. We will utilise the plasma sample bank from a cohort with over 6,000 subjects to screen the lipid species that is closely correlated to insulin resistance and prediabetes.

Presently Dr. MOHD. AKHTAR working as Senior Assistant Professor in the Department of Pharmacology, School of Pharmaceutical Education and Research (Formerly: Faculty of Pharmacy ranked Ist in NIRF Ranking) Jamia Hamdard (Hamdard University) Mahruali Badarpur Road, Sangam Vihar New Delhi 110 062. He did his B.Pharm, M.Pharm Ph.D (Pharmacology) from Jamia Hamdard. Before joining Hamdard, he worked as clinical Pharmacist in Saudi Arabia for 2 and half years and as lecturer in HNB Garhwal University. Has more than 17 years of teaching and research experience. He supervised more than 37 M. Pharm Pharmacology; Pharmacy Practice and M.D students also supervised 7 Ph.D students. His areas of Research include CNS, CVS, Endocrine, drug-drug interaction studies, Pharmacovigilance studies. He has more than 90 research papers in national and international journals of repute. He also received projects like fast track project for young scientist from DST, AICTE, CCRUM. He received scientist of the year 2008 award from NESA, Recipient of 2nd Academic Brilliance Awards 14 for Excellence in research presented by Education Expo 2014. He has presented papers in so many symposiums, conferences and workshops. He is life member of IPS, APTI, IPGA, IHPA Society of Pharmacovigilance and NESA.

Diabetes & Endocrinology

An experienced and caring clinician with extensive experience in caring for patients in government and private set ups. Experienced in modern hospital care set up in Singapore. A brilliant academician with gold medals / honours in almost every subject during medical training, best student of the year 1987, University of Calcutta topper in MBBS First part 1987, followed by Post doctoral and Royal College of UK degrees. Excellent speaker regular at API, ESI, DAI conferences. Extensive experience in medical teaching at under and post graduate levels.

Diabetes & Endocrinology

BIOGRAPHY Dr. Farhan Ahmad Khan currently working as Professor & Head in a Medical College and has more than 10 years of research as well as clinical experience. Serving as Editor-in-chief of an International Peer-reviewed Medical Research Journal and present in the editorial board of reputed journals. He is also the Member of The American College of Clinical Pharmacology, Asian Council of Science Editors. Have vast experience in Training and supervision of Postgraduate students (MD, MSc) in Clinical Pharmacology. Have been involved in Helping Physicians in setting Treatment Guidelines. Invited as Guest Speakers at Scientific meetings/conferences in Sydney, China, Austria.

Pharmacovigilance, Clinical Pharmacology, Immunopharmacology, Therapeutic Drug Monitoring, Rational Use of Drugs, Clinical Trial

Dr. Kshitij Shankhdhar (age 40) is a Diabetologist from Lucknow, India. He has specialized in diabetic foot care and diabetes education. He did his medical graduation in India followed by post graduate trainings and fellowships in European countries. He did his fellowship in diabetic foot at Manchester, UK (Prof AJM Boulton) and observed clinical Podiatry at London, UK (Prof Mike Edmonds). At Oxford, UK he attended the Robert Turner Clinical Research Course (Prof David Matthews) along with Scientist Training Course (Prof Per Henrick Groop) at Helsinki, Finland. He is recipient of Albert Renold Fellowship, given by the European Foundation for the Study of Diabetes. He was selected for the prestigious Gary Sibbald International Scholarship by the Canadian Association of Wound Care. In 2011, at Birmingham, UK he received the 'Highly commended - Innovations in diabetic foot ulcers award' given by Wounds UK. He is the only Indian doctor to hold the fellowship of APWCA (American Professional Wound Care Association) and was selected as a member of the Medical Advisory board of APWCA. He is the only Indian doctor to hold the fellowship of APWH (Academy of Physicians in Wound Healing, Winston-Salem NC 27106). Dr. Kshitij Shankhdhar established the first diabetic foot clinic of north India called Lucknow Diabetic Foot Care Clinic and Research Centre under L.K.Diabetes Centre, Lucknow, India. For 15 years, Dr. Kshitij Shankhdhar has been actively involved in diabetes care and diabetic foot amputation prevention. Dr. Shankhdhar holds the credit of inventing (in the year 2000) - The Samadhan System of Offloading the diabetic foot. His work in the field of Diabetic foot care has been selected for oral presentation at most esteemed international conferences in Diabetology, organized by associations like The International Diabetes Federation, American Diabetes Association, Canadian Diabetes Association, European Association for the Study of Diabetes, Diabetic Foot Study Group (EASD), Wounds UK, Diabetic Foot Global Conference and many others in different parts of the world. In the year 2009, he solely conducted a two day workshop on diabetic foot, organized by the International Diabetes Federation, at Seychelles, Africa in which he trained a number of African doctors and nurses. On 23rd April, 2015 he delivered a 40 minute key note lecture at International Diabetic foot conference at Novosibirsk, Russia. In April 2016, he was faculty speaker at 7th Abu Dhabi wound care conference and also Chairman of a session. Recently, on 14th July; he was conferred with State-of-the-art diabetic foot clinic award for his pioneering work in the field of diabetic foot care in India. This was handed over to him by Dr. N.C. Schaper (Nicolaas), Department of Internal Medicine/Endocrinology, University Hospital Maastricht, The Netherlands during the National Conclave on Diabetic Foot, held at Mumbai, India. Diabetes leads to one amputation every 20 seconds. 85% of these amputations are preventable. Such specialized diabetic foot clinics play a major role in amputation prevention. Dr. Shankhdhar is the Working President of the UPMA - Uttar Pradesh Madhumeh (the word madhumeh means diabetes in Hindi language) Association in the state Uttar Pradesh, India. He had successfully established a first of its kind, UPMA's Medical College of Diabetology, for a structured education program for people with diabetes. He strongly believes in the words of Dr. Elliott Joslin (regarded as the father of modern diabetes care), the person with diabetes who knows the most lives the longest.

Diabetes Medical Care, Diabetes Education, Diabetic foot care (Podiatry)

Dr. Pedro A. Jose is Professor of Medicine and Pharmacology/Physiology, The George Washington University School of Medicine & Health Sciences, Visiting Professor, Third Military Medical University, Chongqing, China, Visiting Professor, Anhui Institute of Cardiovascular Disease, Anhui, China, and Concurrent Professor, Nanjing University School of Medicine, Nanjing, China. The primary goal of Dr. Jose’s research is to determine the genetic and pharmacogenetic bases of human essential hypertension and the metabolic syndrome. Specifically, the mission of his laboratory is to study the role of dopamine, adrenergic, and angiotensin receptor subtypes and dopamine regulatory genes (e.g., G protein-coupled receptor kinase 4 [GRK4], sorting nexins, gastrin) on sodium transport in specific nephron segments and their roles in the pathogenesis and treatment of genetic hypertension and metabolic syndrome. Dr. Jose’s studies are performed in vitro and in vivo, using molecular and cell biological methods, including gene silencing, gene rescue (e.g., AAV vectors), confocal microscopy and biophysical imaging, and integrated physiology in rats, mice, and humans. A key finding of Dr. Jose’s research is the demonstration of the crucial role of gene variants of GRK4 in the pathogenesis and personalized treatment of hypertension. Dr. Jose and his associates have discovered genes that cause high blood pressure when sodium intake is excessive and more importantly, genes that cause high blood pressure when sodium intake is too low. He has published more than 380 scientific articles in book chapters and journals. His articles are currently cited more than 10,000 times, with 57 cited 50 or more times, 19 of which are cited more than 100 times. Four of his articles are covers of scientific journals, six are the subject of editorial commentaries, and two are featured articles. His Hirsch-index is 52. Dr. Jose has received several academic and research awards, including the 2003 Lewis K. Dahl Memorial Lecture (American Heart Association), 2007 Ernest H. Starling Distinguished Lecture (American Physiological Society), 2007 MERIT award (National Institutes of Health), and 2015 Excellence Award for Hypertension Research (American Heart Association).

Metabolic syndrome, Pharmacology, Health Sciences.

Jie Shen M.D., Investigator, Chief Physician Department of (1 ) Endocrinology and Metabolism (2 ) The center of immunological genetics and HLA typing, The First Affiliated Hospital of Nanjing Medical University Academic Position 1. Academic Committee Member for Chinese Diabetes Society Jiangsu Branch 2. Vice chairman for China Microcirculation Society Jiangsu Branch 3. Member of Expert Committee for China Marrow Donor Program 4. Academic Committee Member for China Diabetes and Microcirculation Society 5. Clinical Consultant for UpToDate. 6. Advisory Board Member for Medical Education Culture and Health Committee for the China Revolutionary Committee of the Kuomintang Jiangsu Branch EDUCATION & LISCENSE 6/2014- Ph. Doctor Candidate in Medical Sciences 11/2007-11/2008 Postdoctoral Fellow for NIH, NIDDK , Phoenix USA 12/2001-present Licensed to practice medicine in China 07/2000 M.D. and M.S. in Medical Sciences, Ningxia Medical College, Yinchuan, China (09/1997-07/2000) 07/1986 Graduated from Nanjing Medical University, major in Basic and Experimental Medicine, Nanjing , China (09/1982- 07/1986) Work Experience: 2009-Present : (1 ) Investigator, Chief Physician ,Director, The center of immunological genetics and HLA typing (CDMP data bank lab for Jiangsu Province), (2 ) Investigator, Chief Physician for the Department of Endocrinology and Metabolism, Jiangsu Province Hospital(First Affiliated Hospital of Nanjing Medical University) 2007- 2008 : Postdoctoral Fellowship at the Phoenix Epidemiology and Clinical Research Branch, NIDDK, NIH, in Phoenix, Arizona. 2006-2009: Associate Investigator, Associate Physician, Associate Director, Clinical Scientific Research Center, Jiangsu Province Hospital(First Affiliated Hospital of Nanjing Medical University). 2002-2006: Associate Investigator, Acting Associate Director, HLA genotyping laboratory, Jiangsu Province Hospital(First Affiliated Hospital of Nanjing Medical University) 2001-2003: Physician-in-charge, Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University 1997-2002: Assistant Investigator, Secretary of Scientific Research, Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University 1995-1997: Technician-in-charge, Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University 1989-1995: Technician, Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University 1986-1989: Practice Technician, Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University Research Experience: 2009-Present: Research for Epigenetic Regulation on Obesity and Type 2 Diabetes. Epidemiology Study on Chinese Population HLA Typing and HLA Related Diseases Research ( such as Type 1 Diabetes Subacute Thyroiditis and Thyroid Nodule) Clinical Practice on Endocrine and Metabolic Diseases 2007- 2008 : Postdoctoral Fellowship at the Phoenix Epidemiology and Clinical Research Branch, NIDDK, NIH, in Phoenix, Arizona. The major goal of my research in NIH is to identify the specific role of genetic factors in the etiology of diabetes. This work involves various methods of high throughput genotyping, use of techniques from population genetics and computational statistics to analyze genetic variation in humans. 2006-2009: Co-Investigator, Associate Director, Clinical Scientific Research Center, Jiangsu Province Hospital. 2002-2006: Co-Investigator, Associate Director, HLA genotyping laboratory, Jiangsu Province Hospital 2001-Present: Attending Physician, Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University 1997-2002: Research Associate, Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University 1995-1997: Research Assistant, Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University 1989-1995: Technician, Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University 1986-1989: Practice technician, Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University 1990-1993: Scientific Research Co-operation, Institute of Genetics, School of Life Science , Fudan University. Shanghi, China. 1995-1996: Scientific Research Co-operation, Institute of Biochemistry, Chinese Academy of Sciences. Shanghi, China. 2003-present: Scientific Research Co-operation, Institute of Genomic, Chinese Academy of Sciences. PROFESSIONAL AWARDS 1. Outstanding Scientist for Jiangsu Province 2007. The Organization of Awarding the Prize: The Government of Jiangsu Province 2. The Pathological Study of Macrovascular Disease in Type 2 Diabetic Patients. Rank of Award:Ⅳ Date of Issue: Nov.1995 Certificate No. : 4-144-2 The Organization of Awarding the Prize: Academic Committee of Science and Technology Prize Jiangsu Province , China. 3. The Study on Insulin Receptor Gene Variations and Their Relation With Insulin Resistance. Rank of Award:Ⅲ Date of Issue: Dec.2001 Certificate No. : 3-231-1 The Organization of Awarding the Prize: Academic Committee of Science and Technology Prize Jiangsu Province , China. 4. The Study of Early Diagnosis and Prevention of Type 1 Diabetes Mellitus Rank of Award:Ⅲ Date of Issue: Dec.2001 Certificate No. : 3-230-5 The Organization of Awarding the Prize: Academic Committee of Science and Technology Prize Jiangsu Province , China. 5. The Study of Risk Factors and its Pathology in Type 2 Diabets and its Macrovascular Complications Rank of Award:Ⅲ Date of Issue: Dec.2003 Certificate No. : 3-166-2 The Organization of Awarding the Prize: Academic Committee of Science and Technology Prize Jiangsu Province , China. 6. The Cytomorphological Changes of Smooth Muscle Cell in Various Concentrations of Glucose. Awarded for the Excellent Article The Organization of Awarding the Prize: Academic Committee of Science and Technology Prize , Jiangsu Province , China. 7. The Pathological Study of Glucose Transport Gene on Type 2 Diabetes Mellitus Rank of Award:Ⅳ Date of Issue: Nov.1995 Certificate No. : 4-145-4 The Organization of Awarding the Prize: Academic Committee of Science and Technology Prize Jiangsu Province , China.

Endocrinology and Metabolism,immunological genetics,immunological genetics,Obesity .

Dimitris T. Papadimitriou received his MD, his PhD on Pediatric Endocrinology and his specialty on Pediatrics at the University of Patras, Greece. He subsequently received a master in pediatric endocrinology from the Paris V University, and a master in Medical Pedagogy at Joseph-Fourier University (Grenoble, France), where he worked as a Lecturer (CCU) for 2 years. Since December 2005 he is Director of the Department of Pediatric-Adolescent Endocrinology and Diabetes of the Athens Pediatric Center in Athens and a Scientific Associate - University Scholar of the 3rd Pediatric Clinic of the University of Athens at Attikon Hospital.

Pediatric Endocrinology & Diabetes

Zeev Blumenfeld is MD for Hebrew University and Hadassah Medical School, Jerusalem, and he is the Director for Reproductive Endocrinology for the department Obstetrics & Gynecology. He worked as Director in the year 2010 for Reproductive Endocrinology; he is a Senior Physician for Reproductive Endocrinology and Infertility, OB/GYN. He has an extensive and vast teaching experience in the field of "Reproductive Endocrinology". He taught Director of Endocrinology Course for medical & graduate students, Director of “Physiology of Reproduction” course. He worked as a Reviewer for many scientific Journals. He also has membership for International and National professional societies. He Elected as member of the "Society for Gynecologic Investigation". Worked as Editor in Chief- ‘Clinical Medicine Insight: Reproductive Health’, "Journal of Reproductive Biology and Health".

Prevention of premature ovarian failure (POF) in young women receiving gonadotoxic chemotherapy, Reproductive Endocrinology, Inhibin & Activin in Human Reproduction, Hypophysiotropic and Neuroregulatory Modulation of Fetal Human Pituitary, Infertility and Assisted Reproduction (ART), Immunologic Problems in Infertility

Dr. Lodhi graduated from medical school in 1999. She did her Family Medicine Residency at Virginia Commonwealth University. This is where she recognized her calling in Geriatrics. She then did her fellowship in Geriatrics at George Washington University. In 2011, she became a faculty member at the same department as Assistant Professor of Medicine. Since then, she has been a versatile part of GW Geriatrics and Palliative practice. She believes in maintaining relationships with her patients through the continuum of outpatient, inpatient, post acute and long term care settings. She is also part of GW Palliative care practices, including home based hospice and inpatient hospice unit. Teaching is her passion! She has introduced the medical students, primary care residents to Geriatrics Medicine out of the traditional settings into assisted living facilities, post acute and long term care. Her Geriatrics/scholarly interests include healthy aging, improving care transitions especially through focus on medications and developing multifaceted systems to improve care delivery to seniors, incorporating community resources, deploying available technology to provide patient cantered care.

Geriatrics,Palliative Medicine